AIG
PCRX icon

American International Group’s Pacira BioSciences PCRX Stock Holding History

American International Group’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-24,605
Closed -$719K – 1940
2024
Q1 		$719K Sell
24,605
-219
-0.9% -$6.73K ﹤0.01% 1474
2023
Q4 		$838K Sell
24,824
-209
-0.8% -$6.12K ﹤0.01% 1398
2023
Q3 		$768K Buy
25,033
+549
+2% +$19.8K 0.01% 1366
2023
Q2 		$981K Sell
24,484
-104
-0.4% -$4.3K 0.01% 1263
2023
Q1 		$1M Buy
24,588
+103
+0.4% +$4.1K 0.01% 1211
2022
Q4 		$945K Sell
24,485
-191
-0.8% -$9.29K 0.01% 1241
2022
Q3 		$1.31M Buy
24,676
+296
+1% +$16.5K 0.01% 1075
2022
Q2 		$1.42M Sell
24,380
-952
-4% -$62.4K 0.01% 1060
2022
Q1 		$1.93M Sell
25,332
-1,553
-6% -$104K 0.01% 1036
2021
Q4 		$1.62M Sell
26,885
-575
-2% -$31.7K 0.01% 1168
2021
Q3 		$1.54M Sell
27,460
-919
-3% -$53K 0.01% 1178
2021
Q2 		$1.72K Sell
28,379
-117
-0.4% -$7.41K 0.01% 1196
2021
Q1 		$2K Sell
28,496
-294
-1% -$21K 0.01% 1110
2020
Q4 		$1.72K Sell
28,790
-242
-0.8% -$14.2K 0.01% 1140
2020
Q3 		$1.75M Sell
29,032
-284
-1% -$16.5K 0.01% 1007
2020
Q2 		$1.54M Buy
29,316
+1,055
+4% +$44.1K 0.01% 1049
2020
Q1 		$948K Sell
28,261
-1,401
-5% -$58.2K 0.01% 1133
2019
Q4 		$1.34M Sell
29,662
-527
-2% -$22.4K 0.01% 1182
2019
Q3 		$1.15M Buy
30,189
+4,402
+17% +$176K ﹤0.01% 1230
2019
Q2 		$1.12M Buy
25,787
+342
+1% +$14.5K ﹤0.01% 1256
2019
Q1 		$968K Sell
25,445
-824
-3% -$32.2K ﹤0.01% 1339
2018
Q4 		$1.13M Sell
26,269
-203
-0.8% -$9.47K ﹤0.01% 1199
2018
Q3 		$1.3M Buy
26,472
+478
+2% +$20.7K ﹤0.01% 1270
2018
Q2 		$833K Buy
25,994
+576
+2% +$19.9K ﹤0.01% 1502
2018
Q1 		$792K Sell
25,418
-1,052
-4% -$37.5K ﹤0.01% 1413
2017
Q4 		$1.21M Buy
26,470
+124
+0.5% +$4.91K ﹤0.01% 1250
2017
Q3 		$989K Buy
26,346
+1,970
+8% +$79.3K ﹤0.01% 1347
2017
Q2 		$1.16M Buy
24,376
+2,316
+10% +$107K ﹤0.01% 1196
2017
Q1 		$1.01M Buy
22,060
+1,103
+5% +$47.7K ﹤0.01% 1200
2016
Q4 		$677K Sell
20,957
-54
-0.3% -$1.8K ﹤0.01% 1457
2016
Q3 		$719K Buy
21,011
+32
+0.2% +$1.25K ﹤0.01% 1400
2016
Q2 		$708K Sell
20,979
-2,078
-9% -$102K ﹤0.01% 1389
2016
Q1 		$1.22M Sell
23,057
-158
-0.7% -$9.24K ﹤0.01% 1370
2015
Q4 		$1.78M Sell
23,215
-1,007
-4% -$57K 0.01% 1163
2015
Q3 		$996K Sell
24,222
-2,030
-8% -$124K ﹤0.01% 1466
2015
Q2 		$1.86M Sell
26,252
-2,049
-7% -$161K 0.01% 1193
2015
Q1 		$2.51M Buy
28,301
+968
+4% +$98.2K 0.01% 1059
2014
Q4 		$2.42M Sell
27,333
-986
-3% -$93.3K 0.01% 1047
2014
Q3 		$2.74M Sell
28,319
-1,038
-4% -$101K 0.01% 988
2014
Q2 		$2.7M Buy
29,357
+5,109
+21% +$389K 0.01% 993
2014
Q1 		$1.7M Buy
24,248
+1,988
+9% +$135K 0.01% 1191
2013
Q4 		$1.28M Buy
22,260
+223
+1% +$11.7K 0.01% 1314
2013
Q3 		$1.06M Buy
22,037
+9,129
+71% +$333K 0.01% 1368
2013
Q2 		$374K Buy
+12,908
New +$373K ﹤0.01% 2065

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American International Group's PCRX Position: Q2 2024 in Review

American International Group sold out of Pacira BioSciences (PCRX) in Q2 2024, closing a stake of 24,605 shares — an estimated $719K sold.

American International Group first reported a position in PCRX in Q2 2013 and held it in 44 quarters. The position peaked at $2.74M in Q3 2014. 280 funds tracked by Wall St. Rank hold PCRX as of Q2 2024.

  • American International Group reported no remaining Pacira BioSciences position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 24,605 Pacira BioSciences shares in Q2 2024, an estimated $719K.
  • American International Group first reported a position in Pacira BioSciences in Q2 2013 and held it in 44 quarters.
  • American International Group's Pacira BioSciences position peaked at $2.74M in Q3 2014.
  • 280 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.